"Because conflict-of-interest issues are not confined to medical schools, the American Medical Student Assn. is expanding its influential grading system for such policies to more than 400 teaching hospitals."More info
Consumer Survey - Disclosure of Industry Payments to Physicians
Americans want to know about physician ties to pharmaceutical companies
According to a Prescription Project survey, a majority of Americans (64%) say that it is important to know their physician’s financial ties to pharmaceutical companies and 68% would support legislation requiring pharmaceutical companies to disclose gifts to doctors. The survey showed that most Americans disapprove of even small gifts to physicians and believe that the pharmaceutical industry has a large influence over prescribing decisions.
The pharmaceutical industry spends more than $20 billion annually marketing to physicians, much of that marketing in the form of free gifts – ranging from pens and meals to pharmaceutical samples and continuing medical education classes.
The survey was conducted by the national firm ICR during June 4, 2008 – June 8, 2008; 1009 adults from across the United States responded.
Download the full PDF for more information.
- Date added:
- Jun 16, 2008
"U.S. doctors are bracing for increased public scrutiny of the payments and gifts they receive from pharmaceutical and medical-device companies as a result of the new health law."More info
"The legislation requiring public disclosure of the financial relationships between healthcare vendors and physicians has been widely discussed in policy circles for years. Critics claimed payments for speaking, consulting, research or even the small trinkets and meals delivered during routine sales calls unduly influenced physician choices and inflated healthcare costs. To combat those effects, Congress required public reporting of those payments in a publicly accessible database. The legislation, labeled the Physician Payment Sunshine Act, was included in the 2010 healthcare reform law."More info
Prescription project director Danny Carlat identifies issues with the Physician Payments Sunshine Act requiring further clarification and guidance. Addressing those would ensure that manufacturers can appropriately implement the final rule, and enable consumers to benefit from transparency reports published by the Centers for Medicare & Medicaid Services.More info